The study,titled "Pycnogenol®: supplementary management of symptomatic osteoarthritis with a patch. An observational registry study," by B. Feragalli et al., published in Minerva Endocrinlogica, looked at 67 subjects with osteoarthritis of the knee: 34 were in the control group, 33 in the Pycnogenol group.
Patients in the Pycnogenol group applied a patch containing 110mg of Pycnogenol twice per day for three weeks. Results showed that the Pycnogenol patch, when compared with standard osteoarthritis management, allowed for faster improvement in symptoms and a decrease in the use of non-steroidal anti-inflammatory drugs and painkillers. The patch also, the study revealed, significantly reduced C reactive protein and ESR.
According to the press release, at the end of the three-week treatment, subjects reported, among other improvements:
- 51% improvement of pain score, vs. 19% in the control group
- 33% improvement of knee function, vs. 16.3% in the control group
- 91% of participants did not need physiotherapy during the study, vs. 33% in the control group
- 42.4% of subjects reported no osteoarthritis symptoms, vs. 23.5% in the control group.
Fore more on clinical research and additional information on Pycnogenol, which is available in more than 1,000 dietary supplements and multivitamins, visit www.Pycnogenol.com.